Gail Boudreaux on financial performance
From Elevance Health AGM 2026 | Adjusted EPS Guidance Raised To $26.75 Following Strong Q1 Performance · · Investing 101
“In 2025, we delivered solid performance in a dynamic and challenging environment. We generated $197.6 billion in operating revenue, up 13% from the prior year. We delivered $7.2 billion in operating gain, and we returned $4.1 billion to shareholders through dividends and share repurchases while ending the year with 45.2 million medical members.”
On , Gail Boudreaux, President, Chief Executive Officer & Director at Elevance Health Inc, spoke about financial performance during Elevance Health AGM 2026 | Adjusted EPS Guidance Raised To $26.75 Following Strong Q1 Performance on Investing 101.
About Gail Boudreaux
Gail Boudreaux, president and CEO of Elevance Health, reported at the company's 2026 annual meeting that Elevance Health generated $197.6 billion in operating revenue in 2025, a 13% increase from the prior year, and returned $4.1 billion to shareholders through dividends and share repurchases. She said the company was advancing its "whole health" approach by integrating physical, behavioral, pharmacy, and social care and scaling the use of artificial intelligence across operations. Boudreaux also noted that a shareholder proposal requesting an independent study on the impact of prohibiting corporate contributions to partisan political groups did not pass. During previous earnings calls in 2025, Boudreaux discussed challenges in the Medicaid and ACA markets. In the second quarter, she revised the full-year 2025 adjusted EPS guidance to approximately $30, citing elevated medical cost trends and slower-than-expected Medicaid rate alignment. She also described legal action against what she described as misuse of the independent dispute resolution process under the No Surprises Act, alleging that out-of-network providers had submitted inflated payment requests. In the third quarter, Boudreaux stated that Elevance Health was planning for at least a 125 basis point year-over-year decline in Medicaid margins and noted that if Congress allowed enhanced premium tax credits to expire, it would significantly impact 2026 membership. She emphasized that the company was prioritizing long-term performance over near-term expense leverage.